Tela Bio Inc Expected To Post A Loss Of 63 Cents A Share: Earnings Preview

TELA Bio

08/11/2022 03:13

* TELA Bio Inc  TELA.OQ   TELA.O  is expected to show a rise
in
quarterly revenue when it reports  results on November 9. 
    * The Malvern Pennsylvania-based  company is expected to
report  a
42.0% increase in revenue to $10.865 million from $7.65 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for TELA Bio Inc is for
a
loss of 63 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for TELA Bio
Inc is
$20​, above​ its last closing price of $7.74. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.65       -0.62      -0.79     Missed  -27.8
 Mar. 31 2022  -0.56       -0.56      -0.75     Missed  -34.5
 Dec. 31 2021              -0.55      -0.59     Missed  -7.8​
 Sep. 30 2021  -0.54       -0.52      -0.57     Missed  -8.6
 ​​Jun.        -0.53       -0.52      -0.57     Missed  -9.6
 30 2021                                                
 Mar. 31 2021  -0.49       -0.48      -0.56     Missed  -16.1​
 Dec. 31 2020  -0.42       -0.49      -0.54     Missed  -10.7
 Sep. 30 2020  -0.49       -0.49      -0.53     Missed  -9.2
 This summary was machine generated November 8 at 03:12 GMT.  All
figures in US dollars  unless otherwise stated